PEG-interferon alfa-2a
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PEG-interferon alfa-2a, covering 2019-11-08 to 2022-07-27. Get the full timeline:
Most recent: Clinical Trial Update: Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg [Phase 1, Phase 2]